All questionsDrug interactions: Rinvoq (upadacitinib) in rheumatoid arthritis2 questions · 2 sourcesDrug interactionsDoes RINVOQ interact with food or grapefruit?“Take one pill 1 time a day with or without food Advise patients to avoid food or drink containing grapefruit during treatment with RINVOQ” (opens the source at this quote in a new tab)CopyFlag“Coadministration of RINVOQ tablets with a high-fat/high-calorie meal had no clinically relevant effect on upadacitinib exposures (increased AUCinf by 29% and Cmax by 39% to 60%).” (opens the source at this quote in a new tab)CopyFlagWhat drug interactions does RINVOQ have in rheumatoid arthritis?“Upadacitinib exposure is increased when it is co-administered with a strong CYP3A4 inhibitor (such as ketoconazole, clarithromycin, and grapefruit), which may increase the risk of adverse reactions [see Clinical Pharmacology (12.3)]. Monitor patients with rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondylarthritis, pJIA, or giant cell arteritis closely for adverse reactions when co-administering RINVOQ/RINVOQ LQ with strong CYP3A4 inhibitors. Food or drink containing grapefruit should be avoided during treatment with RINVOQ/RINVOQ LQ.” (opens the source at this quote in a new tab)CopyFlag“Upadacitinib exposure is decreased when it is co-administered with strong CYP3A4 inducers (such as rifampin), which may lead to reduced therapeutic effect [see Clinical Pharmacology (12.3)]. Coadministration of RINVOQ/RINVOQ LQ with strong CYP3A4 inducers is not recommended.” (opens the source at this quote in a new tab)CopyFlag“Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Non-radiographic Axial Spondyloarthritis, pJIA, and Giant Cell Arteritis No dosage adjustment is needed in patients receiving strong CYP3A4 inhibitors [see Drug Interactions (7.1)].” (opens the source at this quote in a new tab)CopyFlag